M&T Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-636
Closed -$62.7K 1641
2024
Q3
$62.7K Sell
636
-437
-41% -$56.4K ﹤0.01% 1580
2024
Q2
$176K Buy
1,073
+411
+62% +$58.5K ﹤0.01% 1494
2024
Q1
$101K Buy
+662
New +$110K ﹤0.01% 1543
2022
Q2
Sell
-32
Closed -$20K 1619
2022
Q1
$20K Buy
+32
New +$16.5K ﹤0.01% 1480

Other funds holding AGL

M&T Bank's AGL Position: Q4 2024 in Review

M&T Bank sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 636 shares — an estimated $62.7K sold.

M&T Bank first reported a position in AGL in Q1 2022 and held it in 4 quarters. The position peaked at $176K in Q2 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • M&T Bank reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • M&T Bank sold 636 Agilon Health shares in Q4 2024, an estimated $62.7K.
  • M&T Bank first reported a position in Agilon Health in Q1 2022 and held it in 4 quarters.
  • M&T Bank's Agilon Health position peaked at $176K in Q2 2024.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on M&T Bank's 13F filing for Q4 2024, filed 6 Feb 2025.